| 摘要 |
<p>The present invention relates to transdermal dosage form (Fig. 1-3) comprising at least one activating agent and at least one inactivating agent. The dosage form (Fig. 1-3) releases the inactivating agent upon disruption of the dosage form (Fig. 1-3) thereby preventing or hindering misuse of the active agent contained in the dosage form (Fig. 1-3).</p> |
